NUCLEIC ACID-ASSOCIATED PROTEINS

The invention provides human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing diso...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BECHA, SHANYA, TANG, Y. TOM, YANG, JUNMING, MASON, PATRICIA, M, WARREN, BRIDGET, A, LAL, PREETI, G, BURFORD, NEIL, ELLIOTT, VICKI, S, NGUYEN, DANNIEL, B, RICHARDSON, THOMAS, W, CHINN, ANNA, M, EMERLING, BROOKE, M, BAUGHN, MARIAH, R, GRIFFIN, JENNIFER, A, HAFALIA, APRIL, J.A, YUE, HENRY, CHAWLA, NARINDER, K, AZIMZAI, YALDA, YUE, HUIBIN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP. L'invention concerne des protéines humaines associées aux acides nucléiques, ainsi que des polypeptides identifiant et codant ces protéines. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin des procédés relatifs au diagnostic, au traitement ou à la prévention des troubles liés à l'expression aberrante des protéines considérées.